International Journal of Clinical Research

Objective: To explore the effect of strict control of plasma transfusion during the process of liver disease patients on treatment efficacy and transfusion adverse reactions. Method: 100 liver disease patients who received plasma transfusion in our hospital from February 2023 to February 2024 were selected as the research subjects. They were randomly divided into a control group and an experimental group, with 50 patients in each group. The control group received routine plasma transfusion, while the experimental group strictly controlled plasma transfusion before, during, and after transfusion. Compare the blood routine, liver function indicators, and incidence of adverse reactions during and after blood transfusion between two groups. Result: After blood transfusion, the hemoglobin level in the experimental group was significantly better than that in the reference group (P<0.05); In terms of liver function indicators, the decrease in ALT, AST, and TBIL in the experimental group was better than that in the reference group (P<0.05); In terms of adverse reactions to blood transfusion, the total incidence rate in the experimental group was significantly lower than that in the reference group (P<0.05). Conclusion: Strict control of plasma transfusion in patients with liver disease can significantly improve the quality of transfusion testing, reduce transfusion adverse reactions, promote the recovery of liver function, and is the key to ensuring safe and effective transfusion.

Liver disease; Plasma infusion; Quality of blood transfusion testing; Routine blood test; Liver function; Adverse reactions of blood transfusion